Navigation Links and a Portfolio of 318 'Genetic' Domain Names to be Auctioned Off at Domain Development Conference

SEATTLE, Sept. 14 /PRNewswire/ --, a leading domain name development company, will release a list of DNA and Genetic developed domain names to be auctioned off on September 16, at 1:30 pm at the Bell Harbor Conference Center Bay Auditorium in Seattle. The domain auction is part of the inaugural Domain Developers Conference being held September 15 – 17.  The live auction event is open to the public.

The auction lot contains the premium domain name and website, as well as an additional 318 DNA and genetics-related informational domain names. Scientists believe DNA sequencing will revolutionize preventative medicine, as knowing the genetic blueprints of an individual will reveal predispositions for specific conditions and diseases such as cancer, diabetes, addiction, etc and lead to 'personalized medicine'.

"Owning a massive amount of Internet Real Estate associated with DNA Sequencing, genetic mapping and personalized medicine can be a windfall for a biotechnology company that wants to control the space and capture the associated Internet search traffic," says Rob Monster, Chairman and CEO of "Companies like Illumina, Complete Genomics, Pacific Biosystems, IBM, Agilent, Alpha Biolab, Ambrygen, Biobasic, Elimbio, Genewiz, Genscript, Ion Torrent, Mpbio, Laragen, Sequenom, Sequetech, Seqwright, etc. could effectively control the marketplace overnight by owning these domains," said Monster.

The auction lot will feature such domains as,,,,,,,,,, and more.

Interested parties can participate in the live auction in-person or online through a real-time Internet interface. Those wanting to submit a proxy bid for the domain and website auction can contact directly for more information and instructions. The auction is managed by Moniker® ( and SnapNames® (, both® companies and providers of domain name registration, management, monetization, and brokerage services. Bidders can follow the auction live and, bid online or in person. Conference details can be found at:

About was founded in 2009 with a simple goal – to help domain investors evolve from a singular dependence on domain parking to a more diversified array of value creation strategies that unlock the potential associated with an intuitive domain name. is based in Seattle and is a leading provider of managed solutions for domain investing serving the needs of individuals and institutions that seek exposure to the domain name asset class.

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shire Proposes to Expand Specialist Gastrointestinal Portfolio
2. MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio
3. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems
6. Mendel Announces US Miscanthus Field Trial Results: Second Year Data Demonstrate High-Yielding, Genetically Diverse Product Portfolio
7. Shires Replenished Portfolio Drives Excellent Quarterly Performance
8. Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
9. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
10. EUCODIS Bioscience Receives EUR 2 Million Cash Injection to Enlarge Product Portfolio and Develop International Markets
11. New Industry Research Identifies "Operational Gap" in Clinical Trial Portfolio Management
Post Your Comments:
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/11/2015)... 2015   MedNet Solutions , an innovative SaaS-based eClinical ... is pleased to announce that it will be a Sponsor ... event, to be held November 17-19 in Hamburg ... demonstrations of iMedNet , MedNet,s easy-to-use, proven ... has been able to deliver time and cost savings ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
Breaking Biology News(10 mins):